FI103730B1 - Molekyylikloonauksella aikaansaadut haiman saarekesoluantigeenit - Google Patents

Molekyylikloonauksella aikaansaadut haiman saarekesoluantigeenit

Info

Publication number
FI103730B1
FI103730B1 FI900759A FI900759A FI103730B1 FI 103730 B1 FI103730 B1 FI 103730B1 FI 900759 A FI900759 A FI 900759A FI 900759 A FI900759 A FI 900759A FI 103730 B1 FI103730 B1 FI 103730B1
Authority
FI
Finland
Prior art keywords
iddm
pancreatic islet
molecular cloning
ica
cells
Prior art date
Application number
FI900759A
Other languages
English (en)
Swedish (sv)
Other versions
FI900759A0 (fi
FI103730B (fi
Inventor
Daniel Rabin
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI900759A0 publication Critical patent/FI900759A0/fi
Application granted granted Critical
Publication of FI103730B publication Critical patent/FI103730B/fi
Publication of FI103730B1 publication Critical patent/FI103730B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI900759A 1989-02-17 1990-02-15 Molekyylikloonauksella aikaansaadut haiman saarekesoluantigeenit FI103730B1 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US31254389 1989-02-17
US44170389A 1989-12-04 1989-12-04
US44170389 1989-12-04

Publications (3)

Publication Number Publication Date
FI900759A0 FI900759A0 (fi) 1990-02-15
FI103730B FI103730B (fi) 1999-08-31
FI103730B1 true FI103730B1 (fi) 1999-08-31

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900759A FI103730B1 (fi) 1989-02-17 1990-02-15 Molekyylikloonauksella aikaansaadut haiman saarekesoluantigeenit

Country Status (14)

Country Link
EP (1) EP0383129B1 (fi)
JP (1) JP2858467B2 (fi)
AT (1) ATE122394T1 (fi)
AU (1) AU626636B2 (fi)
CA (1) CA2010275C (fi)
DE (1) DE69019190T2 (fi)
DK (1) DK0383129T3 (fi)
ES (1) ES2072928T3 (fi)
FI (1) FI103730B1 (fi)
GR (1) GR3017019T3 (fi)
IE (1) IE66997B1 (fi)
IL (1) IL93397A (fi)
NO (1) NO306996B1 (fi)
PT (1) PT93166B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) * 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規ｒｅｇ蛋白質
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
ATE268908T1 (de) 1990-09-07 2004-06-15 Univ California Verfahren zur diagnose und behandlung von diabetes
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
AU8864791A (en) * 1990-10-02 1992-04-28 Trigen Incorporated Antibodies and methods for diagnosis and treatment of diabetes
CA2103159A1 (en) * 1991-05-15 1992-11-16 Ake Lernmark Cloning and expression of human islet glutamic acid decarboxylase autoantigen
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
EP0627934A4 (en) * 1992-02-27 1997-01-08 Univ Leland Stanford Junior EARLY ANTIGEN FOR AUTOIMMUNE DIABETE.
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
WO1997032984A1 (en) 1996-03-06 1997-09-12 Zymogenetics, Inc. DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE
CA2288343A1 (en) * 1997-04-25 1998-11-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3381518D1 (de) * 1982-01-22 1990-06-07 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
DE3687064T2 (de) * 1985-06-14 1993-11-11 Bristol Myers Squibb Co Verfahren zur identifizierung von mit gesteigerter diabetesgefahr assoziierten allelen.
CA1327162C (en) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Method for prophylactically treating an individual for an autoimmune disease
AU632991B2 (en) * 1987-06-24 1993-01-21 Autoimmune, Inc. Treatment of autoimmune diseases by oral administration of autoantigens

Also Published As

Publication number Publication date
EP0383129A3 (en) 1991-07-31
AU4988390A (en) 1990-08-23
PT93166B (pt) 1997-11-28
JP2858467B2 (ja) 1999-02-17
NO306996B1 (no) 2000-01-24
IE900589L (en) 1990-08-17
PT93166A (pt) 1990-08-31
EP0383129A2 (en) 1990-08-22
IL93397A0 (en) 1990-11-29
ES2072928T3 (es) 1995-08-01
DK0383129T3 (da) 1995-10-09
DE69019190T2 (de) 1995-09-14
ATE122394T1 (de) 1995-05-15
CA2010275C (en) 2000-08-29
EP0383129B1 (en) 1995-05-10
IE66997B1 (en) 1996-02-21
FI900759A0 (fi) 1990-02-15
FI103730B (fi) 1999-08-31
DE69019190D1 (de) 1995-06-14
AU626636B2 (en) 1992-08-06
JPH0347133A (ja) 1991-02-28
CA2010275A1 (en) 1990-08-17
NO900474D0 (no) 1990-02-01
GR3017019T3 (en) 1995-11-30
IL93397A (en) 1997-06-10
NO900474L (no) 1990-08-20

Similar Documents

Publication Publication Date Title
FI103730B1 (fi) Molekyylikloonauksella aikaansaadut haiman saarekesoluantigeenit
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
PT835266E (pt) Superantigenios modificados / quimericos e seu uso
ATE53219T1 (de) Htlv iii polypeptide.
DE59010450D1 (de) Toxoplasma gondii-Antigene, ihre Herstellung und ihre Verwendung
DE69535719D1 (de) Fas-antigenbindender ligand
DE68925226D1 (de) Monoklonale Antikörper
ATE364083T1 (de) Immunogene zusammensetzungen gegen eine helicobacterinfektion, verwendung von polypeptiden in diesen zusammensetzungen und nukleinsäurendie besagte polypeptide kodieren
ATE87487T1 (de) Rekombinante hiv-2 polypeptide.
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
EP0293827A3 (en) Assay for leishmaniasis
WO1992007939A3 (en) Polypeptide with 46kd hmfg differentiation antigen binding specificity
DE69011122D1 (de) Rubella-e1 und c peptide.
WO2003097814A3 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
Josephson et al. Hμ chain fragment and monoclonal IgA in a lymphoproliferative disorder
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
KR920002631A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.
KR950000879A (ko) 신규한 인간 면역결핍 바이러스-2(hiv-2)

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: BAYER CORPORATION

FG Patent granted

Owner name: BAYER CORPORATION